Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment

Author(s): Xuqi Li, Qingyong Ma, Qinhong Xu, Wanxing Duan, Jianjun Lei, Erxi Wu

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 17 , 2012

Become EABM
Become Reviewer


Recent studies have demonstrated that the interaction between the cancer and the stroma, play a key role in the development of pancreatic cancer. The desmoplasia, which consists of fibroblasts, pancreatic stellate cells, lymphatic and vascular endothelial cells, immune cells, pathologic increased nerves, and the extracellular matrix (ECM), creates a complex tumor microenvironment that promotes pancreatic cancer development, invasion, metastasis, and resistance to chemotherapy. Thus, the potential approach for targeting the components of this desmoplastic reaction or the pancreatic tumor microenvironment might represent a novel therapeutic approach to advanced pancreatic carcinoma. Novel therapies that target on the pancreatic tumor microenvironment should become one of the more effective treatments for pancreatic cancer.

Keywords: Pancreas carcinoma, stroma, tumor desmoplasia, mechanism, anticancer treatment, therapeutic targets

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [2404 - 2415]
Pages: 12
DOI: 10.2174/13816128112092404
Price: $65

Article Metrics

PDF: 25